76 related articles for article (PubMed ID: 19899534)
1. Management of vernal keratoconjunctivitis: Navigating a changing treatment landscape.
Ali A; Bielory L; Dotchin S; Hamel P; Strube YNJ; Koo EB
Surv Ophthalmol; 2024; 69(2):265-278. PubMed ID: 37890678
[TBL] [Abstract][Full Text] [Related]
2. A Patient-Centered Approach to Vernal Keratoconjunctivitis (VKC): A Podcast.
Larsen AC; Rasmussen MLR
Ophthalmol Ther; 2024 May; 13(5):1061-1069. PubMed ID: 38436902
[TBL] [Abstract][Full Text] [Related]
3. A large prospective observational study of novel cyclosporine 0.1% aqueous ophthalmic solution in the treatment of severe allergic conjunctivitis.
Ebihara N; Ohashi Y; Uchio E; Okamoto S; Kumagai N; Shoji J; Takamura E; Nakagawa Y; Nanba K; Fukushima A; Fujishima H
J Ocul Pharmacol Ther; 2009 Aug; 25(4):365-72. PubMed ID: 19441889
[TBL] [Abstract][Full Text] [Related]
4. Time to onset and duration of action of the antihistamine bepotastine besilate ophthalmic solutions 1.0% and 1.5% in allergic conjunctivitis: a phase III, single-center, prospective, randomized, double-masked, placebo-controlled, conjunctival allergen challenge assessment in adults and children.
Abelson MB; Torkildsen GL; Williams JI; Gow JA; Gomes PJ; McNamara TR;
Clin Ther; 2009 Sep; 31(9):1908-21. PubMed ID: 19843481
[TBL] [Abstract][Full Text] [Related]
5. Management of severe allergic conjunctivitis with topical cyclosporin a 0.05% eyedrops.
Ozcan AA; Ersoz TR; Dulger E
Cornea; 2007 Oct; 26(9):1035-8. PubMed ID: 17893529
[TBL] [Abstract][Full Text] [Related]
6. [Ophthalmology].
Takamura E
Nihon Rinsho; 2009 Nov; 67(11):2157-61. PubMed ID: 19899534
[TBL] [Abstract][Full Text] [Related]
7. [Therapy of allergic conjunctivitis].
Hidasi V
Orv Hetil; 2000 Aug; 141(34):1859-65. PubMed ID: 11006710
[TBL] [Abstract][Full Text] [Related]
8. Vernal keratoconjunctivitis: a severe allergic eye disease with remodeling changes.
Vichyanond P; Pacharn P; Pleyer U; Leonardi A
Pediatr Allergy Immunol; 2014 Jun; 25(4):314-22. PubMed ID: 24438133
[TBL] [Abstract][Full Text] [Related]
9.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
